- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00360451
Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents
Preventing Depression in School Children
Study Overview
Status
Conditions
Detailed Description
Depression is a serious illness that affects a person's mood, thoughts, and physical well-being. Research suggests that approximately one in five children meets criteria for a major depressive episode by the end of high school. These children are at increased risk for a wide range of social, psychological, physical, and achievement-related problems. Thus, the potential benefits of effective and highly transportable depression prevention programs are enormous. The Penn Resiliency Program (PRP) is a school-based group intervention that teaches cognitive behavioral and social problem-solving skills to young adolescents. This study will examine the effectiveness of PRP in preventing symptoms of depression and anxiety among a group of young adolescents.
Participants in this open label study will be randomly assigned to one of three groups: adolescent only PRP, adolescent plus parent PRP, or no treatment control. In adolescent PRP, students will be taught cognitive and behavioral problem solving skills by school counselors and teachers. Parents in PRP will be taught to model and reinforce the skills taught in the adolescent program. Participants in the adolescent program will attend twelve 90-minute group sessions after school hours. Participants in the parent program will attend six 90-minute group sessions. Adolescent participants will attend booster sessions twice per year for 2 to 3 years after the initial treatment has ended. Parents will attend one booster session per year during the follow-up phase. Adolescents' depression and anxiety symptoms will be assessed through questionnaires at baseline, post-treatment, and 6-month intervals for 2 to 3 years following the intervention. Adolescents will also complete questionnaires about their coping behaviors, feelings of hopelessness, and several other outcomes related to depression and anxiety in adolescence. Data will be collected once per year from parents and teachers. Adolescent participants will also be assessed for depression and anxiety disorders each year the child is in the study.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Student with above average levels of depression and anxiety symptoms (students with average or below average symptoms will be enrolled into the study space permitting)
Exclusion Criteria:
- Not a student in a participating school
- Not a student in grades six through eight
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Adolescent only Penn Resiliency Program
|
In adolescent PRP, students learn both cognitive skills (recognizing the link between beliefs and emotions, challenging negative beliefs with evidence, making accurate attributions for events, and accurately assessing the ramifications of negative events) and behavioral problem-solving skills (decision making, assertiveness and negotiation, social skills, and relaxation).
|
|
Experimental: 2
Adolescent plus parent Penn Resiliency Program
|
In adolescent PRP, students learn both cognitive skills (recognizing the link between beliefs and emotions, challenging negative beliefs with evidence, making accurate attributions for events, and accurately assessing the ramifications of negative events) and behavioral problem-solving skills (decision making, assertiveness and negotiation, social skills, and relaxation).
Parent PRP teaches parents to model and reinforce the skills taught in the adolescent program.
|
|
No Intervention: 3
Control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Adolescents' depressive symptoms by self-report
Time Frame: Measured at baseline, post-treatment, and 6-month follow-ups
|
Measured at baseline, post-treatment, and 6-month follow-ups
|
|
Adolescents' symptoms of anxiety by self-report
Time Frame: Measured at baseline, post-treatment, and 6-month follow-ups
|
Measured at baseline, post-treatment, and 6-month follow-ups
|
|
Adolescents' symptoms of depression and anxiety, including clinical levels of symptoms, as assessed by diagnostic interview
Time Frame: Measured at baseline and 6, 18, and 30-month follow-ups
|
Measured at baseline and 6, 18, and 30-month follow-ups
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Adolescents' externalizing symptoms by teacher report
Time Frame: Measured at baseline and 6, 18, and 30-month follow-ups
|
Measured at baseline and 6, 18, and 30-month follow-ups
|
|
Adolescents' attributional style by self-report
Time Frame: Measured at baseline and 6, 18, and 30-month follow-ups
|
Measured at baseline and 6, 18, and 30-month follow-ups
|
|
Parental depression by self-report
Time Frame: Measured at baseline and 6, 18, and 30-month follow-ups
|
Measured at baseline and 6, 18, and 30-month follow-ups
|
|
Parental anxiety by self-report
Time Frame: Measured at baseline and 6, 18, and 30-month follow-ups
|
Measured at baseline and 6, 18, and 30-month follow-ups
|
|
Parental attributional style by self-report
Time Frame: Measured at baseline and 6, 18, and 30-month follow-ups
|
Measured at baseline and 6, 18, and 30-month follow-ups
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Martin E.P. Seligman, PhD, Positive Psychology Center, University of Pennsylvania
- Study Director: Jane E. Gillham, PhD, Swarthmore College & University of Pennsylvania
- Study Director: Karen J. Reivich, PhD, University of Pennsylvania
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01 MH0522070
- DSIR CT-P (Other Identifier: NIMH)
- 5R01MH052270 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on Adolescent only Penn Resiliency Program (Adolescent PRP)
-
University of California, San FranciscoCompletedHIV/AIDSUnited States
-
UNICEFNot yet recruitingMarriage | Marriage AgeTurkey
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)CompletedDepression | Prevention Harmful Effects | Adolescent - Emotional ProblemUnited States
-
Brown UniversityNational Institute of Mental Health (NIMH)CompletedDepression | SuicideUnited States
-
Mathematica Policy Research, Inc.Office of Population Affairs; California Department of Public Health, MCAHCompletedTeen Pregnancy PreventionUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSleep DisturbanceUnited States
-
Boston Children's HospitalCompleted
-
Kaiser PermanenteNational Cancer Institute (NCI)Not yet recruitingSarcoma | Cervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer | Thyroid Cancer | Testicular Cancer | Melanoma (Skin Cancer) | Colon Rectal Cancer
-
Human Development Research Foundation, PakistanUniversity of Liverpool; Institute of Psychiatry, WHO Collaborating Center...CompletedDepression | Anxiety | Psychological Distress | Emotional ProblemPakistan